Atlas Trials

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Clinical trial NCT02090764 · COMPLETED

Trial details

NCT number
NCT02090764
Sponsor
Ferrer Internacional S.A.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Impetigo
Start date
2014-06-01
Primary completion
2015-05-01
Enrollment
412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.